Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,786 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First case report of hemophilia B Leyden in Japan.
Yamashita A, Nagae C, Mori M, Ashikaga T, Kojima T, Taki M. Yamashita A, et al. Int J Hematol. 2017 Jul;106(1):135-137. doi: 10.1007/s12185-017-2194-4. Epub 2017 Feb 7. Int J Hematol. 2017. PMID: 28168417
A Case of Peritoneal Dialysis-Related Peritonitis Due to Moraxella osloensis.
Torigoe K, Yoshidome A, Otsuka E, Tsuji K, Yamashita A, Kitamura M, Takazono T, Sakamoto N, Muta K, Mukae H, Nishino T. Torigoe K, et al. Among authors: yamashita a. Cureus. 2024 Nov 23;16(11):e74294. doi: 10.7759/cureus.74294. eCollection 2024 Nov. Cureus. 2024. PMID: 39717310 Free PMC article.
Preclinical and Clinical Pharmacokinetics of JNJ-75220795, an siRNA Therapeutic Targeting PNPLA3, for Metabolic Dysfunction-Associated Steatohepatitis.
Jeon JY, Ayyar VS, Ouchi S, Fabbrini E, Koshkina A, Prusakiewicz JJ, Dallas J, Yang T, Jian W, Kang L, Cofsky K, Rady B, Tamamura R, Saito Y, Yamashita A, Vaughan T, Wendel S, Makimura H, Csonka D, Goyal N. Jeon JY, et al. Among authors: yamashita a. J Clin Pharmacol. 2024 Dec 9. doi: 10.1002/jcph.6174. Online ahead of print. J Clin Pharmacol. 2024. PMID: 39654352
Enhanced Broad-Spectrum Efficacy of an L2-Based mRNA Vaccine Targeting HPV Types 6, 11, 16, 18, with Cross-Protection Against Multiple Additional High-Risk Types.
Tsukamoto K, Yamashita A, Maeki M, Tokeshi M, Imai H, Fukao A, Fujiwara T, Okudera K, Mizuki N, Okuda K, Shimada M. Tsukamoto K, et al. Among authors: yamashita a. Vaccines (Basel). 2024 Oct 30;12(11):1239. doi: 10.3390/vaccines12111239. Vaccines (Basel). 2024. PMID: 39591142 Free PMC article.
1,786 results